The National Law Journal reports that the jury “in the first federal trial over transvaginal mesh devices awarded $2 million to a woman who alleged that the manufacturer failed to warn about defects in its product that caused her bleeding and pain.” Donna Cisson “claims she had to undergo two surgeries to remove the device, one of C.R. Bard Inc.’s line of Avaulta products, which is inserted surgically into women to treat pelvic organ prolaspse – a condition that can cause urinary incontinence or pain, sometimes during sex. Her case is the first bellwether trial of about 20,000 lawsuits coordinated in multidistrict litigation in Charleston, W.V.” The jury, “finding that Bard failed to warn about a design defect in its product, awarded $250,000 in compensatory damages and $1,750,000 in punitive damages. The jury rejected a claim by her husband, also a plaintiff in the case, for loss of consortium.”
From the American Association for Justice news release.
